-
-
-
-
-
-
-
Nuvation Bio (NUVB) Reiterated at Market Outperform by Citizens Amid Acquisition by GSK
-
-
-
-
-
-
-
Relay Therapeutics (RLAY) PT Raised to $21 at Wells Fargo
-
-
-
-
-
-
-
Raymond James on Relay (RLAY): ' ~60% upside to Relay’s current stock price, and we think with further derisking for a 1L breast cancer study that is conservative'
-
-
-
-
-
-
-
Relay Therapeutics reports subset analysis of breast cancer drug
-
-
-
-
-
-
-
Relay Therapeutics (RLAY) appoints Claire Mazumdar to Board
-
-
-
-
-
-
-
JMP Securities Biotechnology Overview
-
-
-
-
-
-
-
Relay Therapeutics (RLAY) 17536 contracts of December 5 puts trade at 20c
-
456,946 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

